Back

Do we follow the recommendation of anticoagulation withdrawal after electrical cardioversion, in patients with atrial fibrillation?

18 March 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Atrial fibrillation - Clinical Cardioversion and Defibrillation EHRA Premium Access EHRA 2018

About the speaker

Photo
Doctor Maria Vidal Burdeus

University Hospital Vall d'Hebron, Barcelona (Spain)

39 More presentations in this session

Presentation thumbnail
Determinants of progression of persistent to permanent atrial fibrillation - data from the RACE 3 study
Doctor R. De With (Groningen, NL)
Abstract
Presentation thumbnail
The electrocardiographic and echocardiographic factors affecting infarct volume in acute ischaemic stroke
Doctor D. Ranganathan (Montreal, CA)
Abstract
Presentation thumbnail
Impact of incomplete revascularization in atrial fibrillation patients undergoing percutaneous coronary intervention: the afcas registry
Associate Professor M. Proietti (Milan, IT)
Abstract Slides
Presentation thumbnail
Cryptogenic stroke is associated with atrial fibrosis similar to atrial fibrillation
Professor N. Akoum (Seattle, US)
Abstract Slides
Presentation thumbnail
Clinical factors related to successful or unsuccessful cardioversion in the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomized trial
Professor G. Lip (Liverpool, GB)
Abstract

Access the full session

Session thumbnail
Poster session 3 - Atrial fibrillation - Clinical

The Event

Event poster

EHRA 2018

18 March - 20 March 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources